Drug-specific timing and fatality patterns of EGFR-TKI-associated interstitial lung disease in NSCLC-related JADER reports
Naunyn-Schmiedeberg's Archives of Pharmacology · 2026
DOI: 10.1007/s00210-026-05751-6 ↗Kurz gefasst
Fachartikel in der Zeitschrift Naunyn-Schmiedeberg's Archives of Pharmacology, 2026. Verfasst von Burak Pacaci und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Oncology, Marmara University Pendik Training and Research Hospital, Istanbul, Turkey. drpacaci@gmail.com. Hauptthemen laut MEDLINE: Lung Diseases, Interstitial, Lung Neoplasms, Protein Kinase Inhibitors, Carcinoma, Non-Small-Cell Lung. Die Arbeit nennt 25 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medical Oncology, Marmara University Pendik Training and Research Hospital, Istanbul, Turkey. drpacaci@gmail.com.
- Department of Medical Oncology, Marmara University Pendik Training and Research Hospital, Istanbul, Turkey.
Zitieren
APA
Pacaci, B., & Kostek, O. (2026). Drug-specific timing and fatality patterns of EGFR-TKI-associated interstitial lung disease in NSCLC-related JADER reports. Naunyn-Schmiedeberg's Archives of Pharmacology. https://doi.org/10.1007/s00210-026-05751-6
Vancouver
Pacaci B, Kostek O. Drug-specific timing and fatality patterns of EGFR-TKI-associated interstitial lung disease in NSCLC-related JADER reports. Naunyn-Schmiedeberg's Archives of Pharmacology. 2026. doi:10.1007/s00210-026-05751-6
BibTeX
@article{Pacaci2026,
author = {Pacaci, Burak and Kostek, Osman},
title = {Drug-specific timing and fatality patterns of EGFR-TKI-associated interstitial lung disease in NSCLC-related JADER reports},
journal = {Naunyn-Schmiedeberg's Archives of Pharmacology},
year = {2026},
doi = {10.1007/s00210-026-05751-6}
}
EUVIMED